84 related articles for article (PubMed ID: 12926046)
1. Nucleotide excision repair-deficient human cells in culture exhibit decreased survival after 2-chlorodeoxyadenosine treatment.
Lawrenzi J; Bunnell A; Hentosh P
Anticancer Res; 2003; 23(4):3141-5. PubMed ID: 12926046
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
Clingen PH; Arlett CF; Hartley JA; Parris CN
Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 2-chloro-2'-deoxyadenosine incorporation into cellular DNA by quantitative polymerase chain reaction.
Yuh SH; Tibudan M; Hentosh P
Anal Biochem; 1998 Aug; 262(1):1-8. PubMed ID: 9735141
[TBL] [Abstract][Full Text] [Related]
4. The antileukemia drug 2-chloro-2'-deoxyadenosine: an intrinsic transcriptional antagonist.
Hartman WR; Hentosh P
Mol Pharmacol; 2004 Jan; 65(1):227-34. PubMed ID: 14722255
[TBL] [Abstract][Full Text] [Related]
5. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
[TBL] [Abstract][Full Text] [Related]
6. Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.
Avery TL; Rehg JE; Lumm WC; Harwood FC; Santana VM; Blakley RL
Cancer Res; 1989 Sep; 49(18):4972-8. PubMed ID: 2569929
[TBL] [Abstract][Full Text] [Related]
7. Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment.
Bulmer JT; Zacal NJ; Rainbow AJ
Cancer Chemother Pharmacol; 2005 Aug; 56(2):189-98. PubMed ID: 15841377
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
9. Irofulven cytotoxicity depends on transcription-coupled nucleotide excision repair and is correlated with XPG expression in solid tumor cells.
Koeppel F; Poindessous V; Lazar V; Raymond E; Sarasin A; Larsen AK
Clin Cancer Res; 2004 Aug; 10(16):5604-13. PubMed ID: 15328203
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide.
Murray D; Vallee-Lucic L; Rosenberg E; Andersson B
Anticancer Res; 2002; 22(1A):21-6. PubMed ID: 12017289
[TBL] [Abstract][Full Text] [Related]
11. Presence of the anti-leukemic nucleotide analog, 2-chloro-2'-deoxyadenosine-5'-monophosphate, in a promoter sequence alters DNA binding of TATA-binding protein (TBP).
Hartman WR; Walters DE; Hentosh P
Arch Biochem Biophys; 2007 Mar; 459(2):223-32. PubMed ID: 17320040
[TBL] [Abstract][Full Text] [Related]
12. The UV-damaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions.
Moser J; Volker M; Kool H; Alekseev S; Vrieling H; Yasui A; van Zeeland AA; Mullenders LH
DNA Repair (Amst); 2005 May; 4(5):571-82. PubMed ID: 15811629
[TBL] [Abstract][Full Text] [Related]
13. Resistance to 2-chloro-2'-deoxyadenosine of the human B-cell leukemia cell line EHEB.
Cardoen S; Van Den Neste E; Smal C; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Clin Cancer Res; 2001 Nov; 7(11):3559-66. PubMed ID: 11705877
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
15. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
16. XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.
Köberle B; Roginskaya V; Wood RD
DNA Repair (Amst); 2006 May; 5(5):641-8. PubMed ID: 16413230
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
Dregoesc D; Rybak AP; Rainbow AJ
DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
19. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E; Cardoen S; Offner F; Bontemps F
Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.
Wright AM; Paterson AR; Sowa B; Akabutu JJ; Grundy PE; Gati WP
Br J Haematol; 2002 Mar; 116(3):528-37. PubMed ID: 11849208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
